Your browser doesn't support javascript.
loading
Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis.
Dimopoulos, Meletios A; Moreau, Philippe; Augustson, Bradley; Castro, Nelson; Pika, Tomas; Delimpasi, Sosana; De la Rubia, Javier; Maiolino, Angelo; Reiman, Tony; Martinez-Lopez, Joaquin; Martin, Thomas; Mikhael, Joseph; Yong, Kwee; Risse, Marie-Laure; Asset, Gaelle; Marion, Sylvia; Hajek, Roman.
Affiliation
  • Dimopoulos MA; The National and Kapodistrian University of Athens, Athens, Greece.
  • Moreau P; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Augustson B; Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
  • Castro N; Hospital de Cancer de Barretos, São Paulo, Brazil.
  • Pika T; Department of Hemato-Oncology, University Hospital Olomouc, Olomouc, Czech Republic.
  • Delimpasi S; Department of Haematology, General Hospital of Athens, Athens, Greece.
  • De la Rubia J; Hematology Department, University Hospital La Fe, Valencia, Spain.
  • Maiolino A; Instituto COI de Ensino e Pesquisa and Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Reiman T; Department of Oncology, Saint John Regional Hospital, Dalhousie University and University of New Brunswick, Saint John, New Brunswick, Canada.
  • Martinez-Lopez J; Departamento de Hematología, Hospital 12 de Octubre, Complutense University, Madrid, Spain.
  • Martin T; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.
  • Mikhael J; Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, Arizona, USA.
  • Yong K; Department of Haematology, University College Hospital, London, UK.
  • Risse ML; Sanofi, Vitry-sur-Seine, France.
  • Asset G; Sanofi, Chilly-Mazarin, France.
  • Marion S; Sanofi, Cambridge, Massachusetts, USA.
  • Hajek R; Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic.
Am J Hematol ; 98(1): E15-E19, 2023 01.
Article in En | MEDLINE | ID: mdl-35604280

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Limits: Humans Language: En Journal: Am J Hematol Year: 2023 Type: Article Affiliation country: Greece

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Limits: Humans Language: En Journal: Am J Hematol Year: 2023 Type: Article Affiliation country: Greece